Mesenchymal stem cells (MSCS) in immunotherapy

被引：0
作者：
Le Blanc, Katarina [1 ]
机构：
[1] Inst Gustave Roussy, Dept Med, Villejuif, France
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：25 / 26
页数：2
相关论文
共 4 条
[1]   Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells [J].
Le Blanc, K ;
Rasmusson, I ;
Sundberg, B ;
Götherström, C ;
Hassan, M ;
Uzunel, M ;
Ringdén, O .
LANCET, 2004, 363 (9419) :1439-1441
[2]   Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex [J].
Le Blanc, K ;
Tammik, L ;
Sundberg, B ;
Haynesworth, SE ;
Ringdén, O .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2003, 57 (01) :11-20
[3]   Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation [J].
Le Blanc, K ;
Ringdén, O .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (05) :321-334
[4]   Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells [J].
Rasmusson, I ;
Ringdén, O ;
Sundberg, B ;
Le Blanc, K .
TRANSPLANTATION, 2003, 76 (08) :1208-1213
1